Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Renal Insufficiency 2Kidney Failure, Chronic 2Carcinoma, Renal Cell 2Virus Diseases 1Renal Insufficiency, Chronic 1Multiple Myeloma 1Hematologic Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

Rocuronium 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2ziprasidone 1venetoclax 1saponin QA-21V1 1perflutren 1finerenone 1empagliflozin 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Thalidomide 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spironolactone 1Specimen Handling 1Simethicone 1Sevelamer 1Resistance Training 1Quillaja Saponins 1Protein Subunit Vaccines 1Polymorphism, Genetic 1Piperacillin, Tazobactam Drug Combination 1Phlebotomy 1Pentobarbital 1Oxycodone 1Nifedipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Renal Insufficiency, Chronic × Kidney Transplantation × Clear all
NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Massachusetts General Hospital

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡